Indeed, further investigations into isolating mechanisms to harness the protective, while limiting the detrimental, effects of the IL-1/IL-1R1 pathway activation should lead to future treatments not only for AKI but other inflammatory diseases. Here, IL1B is linked to acute kidney injury.